loading
전일 마감가:
$91.14
열려 있는:
$91.56
하루 거래량:
432.20K
Relative Volume:
1.03
시가총액:
$1.97B
수익:
$486.82M
순이익/손실:
$18.78M
주가수익비율:
110.99
EPS:
0.82
순현금흐름:
$100.45M
1주 성능:
+4.05%
1개월 성능:
+37.19%
6개월 성능:
+57.08%
1년 성능:
+50.38%
1일 변동 폭
Value
$90.77
$92.53
1주일 범위
Value
$87.31
$92.53
52주 변동 폭
Value
$52.50
$92.53

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
명칭
Ani Pharmaceuticals Inc
Name
전화
(218) 634-3500
Name
주소
210 MAIN STREET WEST, BAUDETTE, MN
Name
직원
897
Name
트위터
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
ANIP's Discussions on Twitter

ANIP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ANIP
Ani Pharmaceuticals Inc
91.01 1.95B 486.82M 18.78M 100.45M 0.82
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-10 개시 H.C. Wainwright Buy
2025-03-14 개시 Jefferies Buy
2025-03-12 개시 JP Morgan Overweight
2024-12-11 개시 Leerink Partners Outperform
2024-10-11 개시 Piper Sandler Overweight
2024-03-15 개시 CapitalOne Overweight
2023-08-22 재확인 H.C. Wainwright Buy
2023-03-01 개시 Guggenheim Buy
2022-09-07 개시 H.C. Wainwright Buy
2021-11-02 개시 Truist Buy
2020-05-07 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2019-09-12 개시 Guggenheim Buy
2019-05-10 다운그레이드 Raymond James Strong Buy → Outperform
2017-10-16 재확인 Canaccord Genuity Buy
2017-07-31 개시 Canaccord Genuity Buy
2017-02-22 다운그레이드 ROTH Capital Buy → Neutral
2016-06-23 개시 Raymond James Strong Buy
2016-05-24 다운그레이드 Standpoint Research Buy → Hold
2015-11-13 개시 Standpoint Research Buy
2015-09-28 업그레이드 ROTH Capital Neutral → Buy
2015-08-05 재확인 Oppenheimer Outperform
2015-08-04 재확인 ROTH Capital Neutral
2015-07-31 재확인 Oppenheimer Outperform
2015-07-15 재확인 ROTH Capital Neutral
2015-06-23 재확인 Oppenheimer Outperform
2015-05-18 재확인 ROTH Capital Neutral
2015-05-06 재확인 Oppenheimer Outperform
2015-04-10 다운그레이드 ROTH Capital Buy → Neutral
2015-02-26 재확인 ROTH Capital Buy
2015-02-18 재확인 Oppenheimer Outperform
모두보기

Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스

pulisher
Aug 19, 2025

MACD Signals Flash Warning for ANI Pharmaceuticals Inc. StockMarket Performance Recap & Fast Entry High Yield Tips - newsyoung.net

Aug 19, 2025
pulisher
Aug 18, 2025

Ani Pharmaceuticals stock hits 52-week high at 90.43 USD By Investing.com - Investing.com Nigeria

Aug 18, 2025
pulisher
Aug 18, 2025

Ani Pharmaceuticals Executives Sell Shares Amid Market Volatility - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

ANI Pharmaceuticals' Insider Sales: Strategic Liquidity or a Warning Signal for Shareholders? - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Insider Selling at ANI Pharmaceuticals: A Cautionary Signal Amidst Strong Earnings and Analyst Optimism? - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

Ani Pharmaceuticals Insider Sold Shares Worth $801,450, According to a Recent SEC Filing - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock By Investing.com - Investing.com UK

Aug 18, 2025
pulisher
Aug 18, 2025

Ani Pharmaceuticals stock hits 52-week high at 90.43 USD - Investing.com India

Aug 18, 2025
pulisher
Aug 18, 2025

Momentum Screeners Rank ANI Pharmaceuticals Inc. in Top 5 Today2025 Institutional Moves & Real-Time Volume Analysis Alerts - classian.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Will ANI Pharmaceuticals Inc. Hold Gains Into CloseMarket Weekly Review & Consistent Income Trade Ideas - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

ANI gets FDA approval for generic Motegrity - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

ANI Pharmaceuticals, Berkshire Hathaway, Chevron - TradingView

Aug 18, 2025
pulisher
Aug 17, 2025

Using R and stats models for ANI Pharmaceuticals Inc. forecastingStop Loss & Weekly Top Gainers Trade List - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

ANI Pharmaceuticals Inc. stock daily chart insights2025 Support & Resistance & Risk Managed Investment Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 01:40:35 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Trend analysis for ANI Pharmaceuticals Inc. this weekWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

This Insider Has Just Sold Shares In ANI Pharmaceuticals - simplywall.st

Aug 16, 2025
pulisher
Aug 16, 2025

ANI Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsConsistent High Return Strategy - beatles.ru

Aug 16, 2025
pulisher
Aug 16, 2025

Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Short Interest & Breakout Confirmation Trade Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Wall Street Zen - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

Assessing Insider Selling at ANI Pharmaceuticals: Confidence or Concern? - AInvest

Aug 16, 2025
pulisher
Aug 15, 2025

Chart based exit strategy for ANI Pharmaceuticals Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Nikhil Lalwani Sells 56,960 Shares of ANI Pharmaceuticals Inc, Insider Now Owns 411,219 Shares - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Leerink Partners Maintains Buy Rating on ANI Pharmaceuticals with $100 Price Target - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

ANI Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Setups & Entry and Exit Point Strategies - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

ANI Pharmaceuticals' Insider Sale: A Strategic Warning or a Misread Opportunity? - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

Can ANI Pharmaceuticals Inc. Overcome Bearish SentimentBear Alert & Smart Allocation Stock Reports - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 14, 2025

Nikhil Lalwani, president of ANI Pharmaceuticals, sells $4.89m in stock - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock By Investing.com - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

ANI Pharmaceuticals director Haughey sells $1.66 million in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Ani Pharmaceuticals SVP Carey sells $4.3m in shares By Investing.com - Investing.com Australia

Aug 14, 2025
pulisher
Aug 14, 2025

Ani Pharmaceuticals’ Cook sells $35k in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Ani Pharmaceuticals SVP Carey sells $4.3m in shares - Investing.com India

Aug 14, 2025
pulisher
Aug 14, 2025

Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock - Investing.com India

Aug 14, 2025
pulisher
Aug 14, 2025

ANI Pharmaceuticals director Haughey sells $1.66 million in stock By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock By Investing.com - Investing.com Australia

Aug 14, 2025
pulisher
Aug 14, 2025

ANI Pharmaceuticals' Insider Sales: Liquidity or Lack of Confidence? - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Insider Selling at ANI Pharmaceuticals: Liquidity Moves or Lack of Confidence? - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Council approves plans for pharmaceutical manufacturing facility - veronapress.com

Aug 14, 2025
pulisher
Aug 14, 2025

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript - MSN

Aug 14, 2025
pulisher
Aug 13, 2025

Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent

Aug 13, 2025
pulisher
Aug 13, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World

Aug 13, 2025
pulisher
Aug 12, 2025

ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12 - AInvest

Aug 12, 2025

Ani Pharmaceuticals Inc (ANIP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Ani Pharmaceuticals Inc 주식 (ANIP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Leonard Matthew J
Director
Aug 18 '25
Sale
88.17
6,937
611,635
9,392
Walsh Patrick D
Director
Aug 15 '25
Sale
89.05
9,000
801,450
70,048
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Aug 15 '25
Sale
87.15
52,990
4,618,078
531,920
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Aug 14 '25
Sale
89.48
47,010
4,206,455
584,910
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Aug 15 '25
Sale
86.97
20,000
1,739,400
173,226
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
자본화:     |  볼륨(24시간):